Discontinues coronavirus vaccination with AstraZeneca as announced on Wednesday (7/4) the region of Castile and Leon Spain pending the publication of the European Medicines Agency (EMA) report on the possible association of the vaccine with cases of thrombosis.
“Applying the precautionary principle, the health authorities in this area decided to discontinue vaccination against Covid-19 with AstraZeneca vaccine/ University of Oxford “, it is mentioned in an announcement.
«The precautionary measure is in anticipation of the publication of the… conclusion of the European Medicines Agency (EMA) meeting todayIs added, as broadcast by the Athenian News Agency.
The EMA, which holds a press conference on the subject at 17.00 Greek time, announced on Tuesday (6/4) that the investigation into whether the AstraZeneca vaccine against Covid is linked to the rare clot formation that has been reported in some countries.
In mid-March, Spain, along with other countries, suspended the AstraZeneca vaccine to resume its use a few days later, following the green light from the EMA, which ruled that the benefits of the vaccine continued to outweigh the benefits. of risks and that its use is safe.
The Spanish health authorities have approved the vaccine for people between the ages of 18 and 65 and for still active front-line workers over the age of 65.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.